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Summary 
This study examined nitric oxide (NO) production, oxidative load 
and endothelium-dependent relaxation (NO-dependent and NO-
independent) in adult male borderline hypertensive (BHR) and 
spontaneously hypertensive (SHR) rats as compared to 
normotensive Wistar-Kyoto (WKY) rats. Systolic blood pressure 
(BP) was determined by tail-cuff. NO production was determined 
by conversion of [
3H]-L-arginine. Conjugated dienes (CD) and 
concentrations of thiobarbituric acid-reactive substances (TBARS) 
were measured for assessment of oxidative load. Vascular 
function was investigated in rings of the femoral artery (FA) 
using a wire myograph. BP of WKY, BHR and SHR was 106±2, 
143±3 and 191±3 mm  Hg, respectively (p<0.01 for each). 
Significant left ventricle (LV) hypertrophy and elevated levels of 
CD and TBARS in the LV were present in BHR and SHR as 
compared to WKY. NO production was elevated significantly in 
the aorta of BHR and SHR vs. WKY as well as in the LV of SHR 
vs. WKY. Acetylcholine (ACh)-induced relaxation of the FA was 
reduced significantly in both BHR and SHR vs. WKY. The NO-
dependent component of ACh-induced relaxation had increasing 
tendency in hypertensive groups and it correlated positively with 
BP. The NO-independent component of vasorelaxation was 
reduced significantly in BHR and SHR vs. WKY and it correlated 
negatively with BP. In conclusion, the results showed that 
endothelial dysfunction in the experimental model of borderline 
hypertensive and hypertensive rats is NO-independent. The 
results suggest that borderline hypertension represents a risk of 
other cardiovascular disorders which is qualitatively similar to 
that of fully developed hypertension. 
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Introduction 
 
  Chronic hypertension is generally considered to 
be a risk factor of several cardiovascular diseases. 
However, prehypertension is not a disease category 
(Chobanian et al. 2003) and relatively little attention has 
been paid to prevention of cardiovascular risk resulting 
from marginal elevation of blood pressure (BP) in adult 
individuals. Although the vascular mechanisms involved 
in prehypertension and hypertension are not well-defined, 
there are studies suggesting the involvement of 
endothelial dysfunction (ED) in conduit and resistance 
arteries in association with altered nitric oxide (NO) 
production and oxidative stress, which may significantly 
contribute to the pathogenesis of hypertension by 
increasing peripheral vascular resistance. 
  Observations in spontaneously hypertensive rats 
(SHR), a widely used experimental model of human 
essential hypertension (Yamori and Okamoto 1973, 
Pintérová  et al. 2011, Kuneš et al. 2012), showed 
considerable differences related to ED (Vapaatalo et al. 616   Púzserová et al.   Vol. 62 
 
 
2000, Török 2008, Gündüz et al. 2011). As shown in the 
literature, ED in SHR depends on several factors 
including age, artery size and methodological approaches 
(Bernatova  et al. 2009). Since hypertension in SHR 
occurs already at juvenile age (about 5-8 weeks), it is 
impossible to examine metabolic and vascular alterations 
in the prehypertensive period in adult (12+ week-old) 
SHR. For this reason, borderline hypertensive rats (BHR) 
are more suitable for investigating the early stage of 
hypertension development in adulthood, which is obvious 
in the human population, and needs to be better 
understood.  
  Borderline hypertensive rats, an experimental 
model of human prehypertension and early stage 
hypertension, can be produced by mating spontaneously 
hypertensive dams with normotensive sires (Lawler et al. 
1980, Fuchs et al. 1998, Bernatova et al. 2007, 
Pechánová  et al. 2009). Resting systolic BP of adult 
offspring in the first-generation is in the range 130-150 
mm  Hg (Sanders and Lawler 1992, Mansi and Drolet 
1997, Bernatova et al. 2007), which allows investigating 
the vascular function in adult animals with mild elevation 
of blood pressure. 
  In general, ED is characterized by alterations in 
the production and/or bioavailability of endothelium-
derived relaxing factors (EDRFs) and endothelium-
derived constricting factors (EDCFs) (Török 2008, 
Vanhoutte 2009). The functional status of the 
endothelium is usually tested by the acetylcholine (ACh) 
test in isolated pre-constricted arteries. ACh-induced 
relaxation results from stimulated release of at least three 
different vasodilating agents from the endothelial cells – 
nitric oxide (NO), prostacyclin (PGI2), and endothelium-
derived hyperpolarizing factor(s) (EDHFs) (Fujimoto and 
Fujimoto 2001, Stankevicius et al. 2003, Gündüz et al. 
2011). NO seems to be the most powerful vasorelaxing 
factor, however the extent of NO-dependent relaxation 
depends on the size of the artery. The greatest NO-
dependency of vasorelaxation was observed in the aorta, 
while the role of NO is much smaller in the regulation of 
endothelial function in the small resistant arteries where 
EDHFs seem to be more important (Shimokawa et al. 
1996, Török 2008). 
  In this study we investigated vascular function 
(contractile responses and vasorelaxation including its 
NO-dependent and NO-independent components) in the 
femoral artery as well as the oxidative load and NO 
production in selected tissues of normotensive, borderline 
hypertensive and spontaneously hypertensive rats in order 
to determine the role of NO and the seriousness of 
vascular changes in conditions of borderline hypertension 
in adulthood. 
 
Methods 
 
Animals 
  All rats used in the present study were born in 
our certified animal facility (Institute of Normal and 
Pathological Physiology SAS) in order to maintain the 
same environmental background of all animals. Adult, 
22-week old males of Wistar-Kyoto (WKY, negative 
control), BHR and SHR (positive control) were used in 
this study (n=10 each). BHRs were the first filial 
offspring of SHR dams and normotensive WKY sires. 
Rats were housed in groups of 5 rats per cage (35/55/20 
cm), each genotype separately, in an air-conditioned 
room at constant temperature (22-24  °C) and humidity 
(45-60 %) at a 12:12-h light/dark cycle (06:00-18:00 h 
lights on) and maintained on a standard pellet diet and tap 
water  ad libitum. Drinking water consumption was 
measured in each group from the age of 12 weeks 
(beginning of adulthood) to 22 weeks of age (end of 
experiment). All procedures used were in accordance 
with the EU Directive 2010/63/EU and they were 
approved by the State Veterinary and Food 
Administration of the Slovak Republic. 
 
Experimental design 
 Twenty-two-week-old  Wistar-Kyoto,  borderline 
hypertensive and spontaneously hypertensive rats were 
killed by decapitation after a brief CO2 anesthesia between 
7:30 and 9:30 AM. Wet mass of the left heart ventricle 
(LVM) and body mass (BM) were determined for 
calculation of the relative left ventricular mass (LVM/BM) 
to evaluate the degree of cardiac hypertrophy. 
 
Blood pressure and heart rate 
  Systolic blood pressure (BP) and heart rate (HR) 
were determined non-invasively in conscious rats by tail-
cuff plethysmography (using the Statham Pressure 
Transducer P23XL, Hugo Sachs, Germany). One week 
before experimentation, the rats were handled and 
accustomed to the tail-cuff procedure of blood pressure 
recording in three independent sessions (Durante et al. 
2010). Blood pressure and heart rate were determined 
between 9:00-12:00 h and were calculated as the average 
value of 4-5 successive measurements (Puzserova et al. 
2013). 2013   Endothelial Function of Hypertensive Rats    617 
 
 
Assessment of vascular reactivity by wire myograph 
  Femoral arteries (FA) were carefully dissected, 
immediately immersed in modified cold physiological 
salt solution (PSS) and cleaned of adipose or connective 
tissue. Arteries were then cut into segments (1.33±0.04 
mm long) and mounted as ring-shaped preparations in the 
Mulvany-Halpern style small vessel wire myograph 
chamber (Dual Wire Myograph System 410A, DMT A/S, 
Aarhus, Denmark) to determine the vascular reactivity 
during isometric conditions as described elsewhere 
(Mulvany and Halpern 1977). After mounting in 
oxygenated (5  % CO2, 95  % O2 mixture) PSS 
(composition in mmol/l: NaCl 118.99, KCl 4.69, 
NaHCO3 25, MgSO4.7H2O 1.17, KH2PO4 1.18, 
CaCl2.2H2O 2.5, Na2EDTA 0.03, glucose 5.5), pH 7.4, at 
37  °C, a standardized computer-assisted normalization 
procedure was performed to set the pre-tension of the 
arteries. The arteries were set to a circumference 
equivalent to 90 % of that which they would have at a 
transmural pressure of 100 mm  Hg (90  % of the 
normalized inner circumference). The change in wall 
tension (active wall tension) was calculated as measured 
force divided by the double segment length and expressed 
in mN/mm. Resting wall tension (which arises from the 
properties of the passive elements in the vascular wall) 
was also determined after the normalization procedure 
(Mulvany and Halpern 1977). 
 
Femoral artery reactivity 
  Before the start of the normalization procedure, 
the vessels were allowed to stabilize in PSS for 30 min. 
The experimental protocol consisted of the following 
steps: 45 min after normalization, PSS was changed to 
KPSS in which NaCl was exchanged for an equimolar 
concentration of KCl (in whole KPSS 125 mmol/l for 
2  min) followed by wash-out with PSS to baseline 
(15 min). After noradrenaline (NA) addition (10 μmol/l, 
maximal stimulation, waiting to plateau) and wash-out 
(PSS, 20 min), pre-constriction was achieved by 
serotonin (5-hydroxytryptamine, 1 μmol/l, waiting to 
plateau). When the contraction of the femoral artery to 
serotonin reached a steady state, increasing 
concentrations of the vasodilator acetylcholine (ACh, 
0.001 to 10 μmol/l) were added in cumulative manner to 
perform endothelium-dependent concentration-response 
curves (Fujimoto and Fujimoto 2001). When the 
concentration-relaxation curve was completed, the drugs 
were washed-out (PSS, 20 min) and the same experiment 
was repeated in presence of N
G-nitro-L-arginine methyl 
ester (L-NAME, nitric oxide synthase inhibitor, 
300 μmol/l) after a 25-min pre-incubation period. In the 
presence of L-NAME, we could preclude ACh-induced 
NO release, the curve thus represented L-NAME-resistant 
(i.e. NO-independent) component of ACh-induced 
relaxation. When concentration-response curve for ACh 
was completed, drugs were wash-out (PSS, 30 min), and 
the nitric oxide donor sodium nitroprusside (SNP, 0.001 
to 10 μmol/l) was added by cumulative manner to the 
pre-constricted arteries (serotonin, 1 μmol/l). 
  After the following wash-out (PSS, 20 min), the 
femoral artery rings were stimulated with high 
concentration of K
+ (125 mmol/l) in depolarizing solution 
to induce maximal contraction (PSS was changed to 
KPSS) and then left to achieve plateau. The maximal 
tension achieved with depolarizing solution was set as 
100 % to express the active tension generated by different 
vasoconstrictors (Puzserova and Bernatova 2010). 
  The NO-dependent (i.e. L-NAME-sensitive) 
component of endothelium-dependent relaxation was 
calculated as the difference between ACh-induced 
relaxation before and after acute L-NAME pre-treatment 
(Paulis et al. 2008, Puzserova and Bernatova 2010) and 
expressed as area under the curve (AUC, in arbitrary 
units – a.u.) based on the individual concentration-
response curves (Puzserova and Bernatova 2010). The 
extent of vasorelaxation was expressed in relative values 
as the percentage of the initial contraction induced by 
serotonin as well as in absolute values as agonist-induced 
wall tension decrease (mN/mm) (Webb et al. 1987, 
Hansen and Nedergaard 1999, Líšková et al. 2011). 
Vasoconstrictions were determined as the maximal 
tension and they were expressed as active wall tension in 
mN/mm. Responses to each drug concentration were 
always allowed to stabilize before addition of a 
subsequent dose of the same drug or of another drug 
(Asano et al. 1982, Webb et al. 1987). 
  All chemicals used were purchased from Sigma-
Aldrich (Germany), except noradrenaline 
hydrogenotartras (Zentiva, Czech Republic). NA was 
prepared daily. All drugs were dissolved in distilled water 
and concentrations were expressed as final concentration 
in the myograph chamber. 
 
Oxidative stress markers 
  For assessment of oxidative load, conjugated 
dienes (CD) and concentrations of thiobarbituric acid-
reactive substances (TBARS) were measured in the left 
ventricle (LV), as described previously (Hu et al. 1989), 618   Púzserová et al.   Vol. 62 
 
 
with some modifications. 
  To determine TBARS, 1 ml of tissue 
homogenate of the left ventricle (10  % w:v, in 1.15  % 
KCl in 0.01 mol/l phosphate buffer, pH 7.4) was added to 
2 ml of 7.5  % trichloroacetic acid and mixed. After 
centrifugation at 1  000g for 10 min, 1 ml of the 
supernatant was added to 0.5 ml of 0.7 % 2-thiobarbituric 
acid and incubated in a water bath at 100 °C for 10 min. 
After cooling, TBARS were measured at 532 nm (GBC 
UV/VIS 911 A). An extinction coefficient of 
156 000 mol
−1.l.cm
−1 was used for calculation of the 
results. 
  CD were determined from the same tissue 
homogenates as TBARS. Homogenate (0.4 ml) was 
mixed with 1.5 ml chloroform:methanol (1:2) for 1 min, 
and 0.5 ml of chloroform was added and mixed for 30 s. 
Afterwards, 0.5 ml of deionized water was added and 
mixed for additional 30 s. After centrifugation for 10 min 
at 1  000g, 0.5 ml of the chloroform (lower) layer was 
removed and dried under nitrogen. The lipid was 
dissolved in 2 ml of cyclohexane, and conjugated dienes 
were measured at 233 nm using an extinction coefficient 
of 27 000 mol
−1.l.cm
−1. 
  All chemicals used were purchased from Sigma-
Aldrich (Germany) and Merck Chemicals (Germany). 
 
Nitric oxide synthase activity 
  Total NO synthase (NOS) activity was measured 
in tissue homogenates of the aorta and left ventricle 
(200  mg/ml) by determination of [
3H]-L-citrulline 
formation from [
3H]-L-arginine, as described previously 
(Púzserová  et al. 2006, Puzserova et al. 2013) and 
expressed as pmol/min/mg of tissue proteins as 
determined by the Lowry method (Lowry et al. 1951). 
Briefly, crude homogenates of the aorta and LV 
containing 200 mg of wet tissue per 1 ml of 
homogenization solution containing 50 mmol/l Tris-HCl, 
pH 7.4 and 1  % Protease Inhibitor Cocktail (Sigma, 
Germany) were centrifuged at 10  000 g for 10 min at 
4  °C. After centrifugation, 50 µl of supernatant was 
incubated in the presence of 10 μmol/l [
3H]-L-arginine 
(MP Biomedicals, USA, 50 Ci/mmol), 5 μg/ml 
calmodulin, 0.5 mmol/l β-NADPH, 250 µmol/l 
tetrahydrobiopterin, 4 µmol/l FAD, 4 µmol/l FMN, 
1 mmol/l  Ca
2+, 1 mmol/l Mg
2+ in the total volume of 
100  µl. After 20-min incubation at 37  °C, the reaction 
was stopped by 1 ml of ice-cold stop solution containing 
20 mmol/l HEPES, pH 5.5, 2 mmol/l EDTA, 2 mmol/l 
EGTA and 1 mmol/l L-citrulline and applied to 50WX-8 
Dowex columns (Na
+ form). [
3H]-L-citrulline was eluted 
by 1 ml of distilled water and determined by liquid 
scintillation counting (Perkin Elmer Liquid Scintillation 
Analyzer, TriCarb 2910TR). 
 
Statistical analysis 
  Data are presented as group mean values ± SEM 
of the number (n) of observations. Results were analyzed 
by analysis of variance (ANOVA). One-way ANOVA 
was used to compare basic biometric and cardiovascular 
parameters, basal tension and inner diameter, vascular 
constrictions, nitric oxide synthase activity, CD and 
TBARS concentrations. In case of significant results 
pairwaise comparison with Bonferroni adjustment was 
employed. Concentration response curves were compared 
using two-way ANOVA, followed by vertical contrast 
with Bonferroni adjustment. Homogeneity of variances 
and normality of distribution were tested by Levene’s test 
and by Shapiro-Wilk’s test, respectively. To assess 
depression present at high concentration of ACh-
cumulative concentration response curves, the maximal 
response and the response at higher ACh concentration at 
a particular response curve was compared with Dunnet’s 
test (see Fig. 2). Means were considered to differ 
significantly when p<0.05. 
 
Results 
 
Basic biometric and cardiovascular parameters, NO 
production and oxidative stress markers 
  Systolic blood pressure, heart rate, body mass, 
water intake and LVM/BM ratio of WKY, BHR and SHR 
rats are shown in Table 1. Normalized inner diameter was 
decreased by 10 % in SHR and increased by 5 % in BHR 
compared to WKY (Table 1). There was a significant 
positive correlation between normalized inner diameter at 
13.3 kPa and BM (r=0.58, p=0.006, n=21). However, 
there were no significant differences in the resting FA 
wall tension of borderline hypertensive and hypertensive 
rats vs. WKY rats (Table 1). There were also no 
significant differences in the FA segment length after 
mounting among the groups (Table 1). 
  The NOS activity in the aorta was enhanced by 
81 % in BHR and by 106 % in SHR vs. WKY (p<0.01; 
Fig. 1). In the left ventricle, NOS activity was increased 
only in SHR, as compared to both BHR and WKY 
(p<0.01; Fig. 1). Additionally, there were significant 
increases in TBARS and CD concentrations in the left 
ventricle of BHR and SHR (Table 1). 
 2013   Endothelial Function of Hypertensive Rats    619 
 
 
Table 1. Basic biometric and cardiovascular parameters, oxidative stress markers, basal tension and inner diameter of adult Wistar-
Kyoto (WKY), borderline hypertensive (BHR) and spontaneously hypertensive (SHR) rats. 
 
  WKY BHR  SHR 
Water intake (ml/100 g/day)  8.1±0.2 8.9±0.2**  9.9±0.2**
++ 
BM (g)  425.7±9.9 481.7±5.9** 385.3±10.1**
++ 
BP (mm Hg)  106±2 143±3**  191±3**
++ 
HR (bpm)  385±18 405±13  545±14**
+ 
LVM/BM (mg/g)  1.45±0.02 1.63±0.05*  2.18±0.05**
++ 
TBARS-LV (nmol/g)  8.25±0.48 13.99±1.64**  15.55±0.75** 
CD-LV (nmol/g)  1054±26 1238±78**  1813±40**
++ 
FA length (mm)  1.33±0.06 1.32±0.07  1.36±0.08 
ND (μm)  769±12 806±11*  690±13**
++ 
WT (mN/mm)  0.91±0.07 0.92±0.05  0.76±0.06 
 
Values represent mean±SEM of 7-10 rats. BM – body mass, BP – blood pressure, CD – conjugated dienes, FA – femoral artery, HR – 
heart rate, LV – left heart ventricle, LVM/BM – left ventricular mass-to-body mass, ND – normalized inner diameter of the femoral artery 
at 100 mm Hg, TBARS – thiobarbituric acid-reactive substances, WT– resting wall tension of the femoral artery. ** p<0.01, * p<0.05, 
compared to WKY rats; 
++ p<0.01, 
+ p<0.05, compared to BHR rats 
 
 
 
 
Fig. 1. Nitric oxide synthase activity of adult Wistar-Kyoto (WKY), 
borderline hypertensive (BHR) and spontaneously hypertensive 
(SHR) rats. LV – left heart ventricle. Values represent mean±SEM 
of 6-8 rats. **  p<0.01, compared to WKY rats; 
++ p<0.01, 
compared to BHR rats 
 
 
Vascular responsiveness to vasoconstrictors 
 Both  noradrenaline  (10  μmol/l) and serotonin 
(1 μmol/l) induced contractile responses in the femoral 
arteries with intact endothelium; the maximum 
contractions are shown in Table 2. NA-induced responses 
were biphasic: a transient contraction (early response, 
phasic contraction), which occurred within the first 10-
15  s and returned nearly to baseline was followed by 
sustained contraction (delayed response, tonic 
contraction), which reached steady maximum levels at 
5  to 20 min (Fig. 2D). Maximum phasic and tonic 
contraction induced by NA was significantly greater in 
SHR than in WKY, but unchanged in BHR vs. WKY 
(Table 2). However, only tonic contraction induced by 
NA determined in relative values (calculated as 
percentage of maximal response induced by KPSS) was 
significantly greater in SHR than in WKY (Table 2). 
  In the arteries pre-treated with the NOS 
inhibitor, the response to serotonin was augmented as 
compared to responses before L-NAME administration 
(Table 2). There were no significant changes in serotonin 
responses after L-NAME administration in BHR and 
SHR rats as compared to WKY rats. However, the 
difference between serotonin-induced contraction after 
and before L-NAME (to reveal basal, non-stimulated NO 
synthesis) was significantly increased in BHR rats 
compared to WKY and SHR, but comparable between the 
WKY and SHR groups (Table 2). 
  The absolute values for the maximum responses 
to KPSS were similar among the groups (Table 2). 
 
Endothelium-dependent and -independent vasorelaxation 
  ACh (1 nmol/l - 10 μmol/l) and SNP (1 nmol/l - 
10 μmol/l) relaxed the femoral artery in a concentration-
dependent manner (Figs 2, 3A, 3C, 4A, 4C). Since 
serotonin (1 μmol/l) induced a reduced response in SHR 
vessels, resulting in a smaller pre-relaxation active 
tension level as compared to WKY (Table 2), the results 
were quantitatively expressed as mN/mm. ACh in 
serotonin-contracted femoral arteries could not induce a 
sustained relaxation and femoral arteries started to 
constrict again after a transient relaxation response 
(Fig.  2). WKY vessels relaxed significantly more in 620   Púzserová et al.   Vol. 62 
 
 
Table 2. Vascular constrictions induced by noradrenaline, high-potassium solution, pre-relaxation active tension responses induced by 
serotonin and maximal vasorelaxations based on the individual concentration-response curves of the femoral artery of Wistar-Kyoto 
(WKY), borderline hypertensive (BHR) and spontaneously hypertensive (SHR) rats. 
 
  Vasoconstriction (mN/mm) 
  WKY BHR  SHR 
NA – phasic  1.07±0.17 1.39±0.16  1.68±0.29* 
NA – tonic  1.13±0.19 1.20±0.22  2.30±0.22**
++ 
Ser before L-NAME  7.41±0.15 7.07±0.42  6.05±0.50* 
Ser after L-NAME  8.94±0.31
xx 9.90±0.40
xx 7.80±0.47
++xx 
∆ Ser after and before L-
NAME 
1.53±0.30 2.83±0.42*  1.76±0.22
+ 
KPSS  9.17±0.90 8.99±0.58  9.78±0.48 
  Relative vasoconstriction (%) 
 WKY  BHR  SHR 
NA – phasic  11.72±1.76 15.60±1.59 16.79±2.36 
NA – tonic  13.46±3.19 11.41±1.34 23.35±1.68**
++ 
Ser before L-NAME  85.57±8.41 77.04±6.65 62.09±4.69* 
Ser after L-NAME  102.04±8.13 112.76±7.28
xx 79.82±3.15*
++xx 
  Maximal vasorelaxation (mN/mm) 
 WKY  BHR  SHR 
ACh before L-NAME  4.80±0.15 3.96±0.12**  2.83±0.19**
++ 
ACh after L-NAME  4.54±0.36 3.68±0.28  1.99±0.40**
++xx 
 
Values represent mean±SEM of 7-10 rats. Δ – difference, ACh – acetylcholine, KPSS – high-potassium physiological salt solution 
(identical with PSS, except with NaCl replaced by KCl on an equimolar basis), NA – noradrenaline (10 µmol/l), L-NAME – pre-treatment 
with N
G-nitro-L-arginine methyl ester (300 μmol/l, 25 min), Ser – serotonin (1 µmol/l). ** p<0.01, * p<0.05, compared to WKY rats; 
++ p<0.01, 
+  p<0.05, compared to BHR rats; 
xx p<0.01, 
x  p<0.05, compared to the respective value without L-NAME. Receptor-
independent, maximum contraction response to KPSS (125 mmol/l K
+) is expressed as 100  % for calculation of the relative 
vasoconstrictions. 
 
 
response to high, yet not to low acetylcholine 
concentrations than did BHR and SHR vessels (Figs 3A, 
4A). In BHR and SHR, relaxing responses produced by 
ACh at concentrations greater than 0.3 μmol/l were 
smaller than maximal relaxations of the given genotype 
(Figs 2, 3A, 3B, 4A, 4B). Results revealed a greater 
endothelial dysfunction in SHR as compared to BHR 
(Figs 3A, 4A). However, there were small but significant 
differences in the relative values of ACh-induced 
relaxations between BHR and SHR (Fig. 4A). Maximal 
absolute relaxations induced by ACh, determined from 
the individual concentration-response curves, are shown 
in the Table 2. Relative maximal relaxations induced by 
ACh (based on the individual concentration-response 
curves) were significantly smaller in SHR 
(58.47±2.52  %, p<0.01) and BHR (60.88±2.75  %, 
p<0.05) than in WKY (68.88±1.68 %). Inhibition of nitric 
oxide synthesis with L-NAME in WKY and BHR had no 
effect on the maximal vasorelaxation, however it reduced 
significantly in SHR (Table 2). When the arteries were 
pre-treated with L-NAME, the femoral arteries from 
BHR and SHR rats responded by smaller relaxation to 
ACh than did the normotensive WKY arteries (Figs 3B, 
4B). The NO-dependent component of ACh-induced 
relaxation, calculated as area under the individual curves, 
had increasing tendency in WKY, BHR and SHR 
(4.15±1.53 a.u., 4.80±1.23 a.u., 5.18±1.04 a.u. calculated 
from absolute relaxations and 102±17 a.u., 118±17 a.u., 
146±16 a.u. calculated from relative relaxations, 
respectively, n.s.) rats. However, significant positive 
correlation was found between systolic BP and NO-
dependent vasorelaxation (Fig. 6B). The NO-dependent 2013   Endothelial Function of Hypertensive Rats    621 
 
 
   
   
 
Fig. 2. Representative traces showing the typical relaxation response of serotonin (Ser) pre-contracted femoral artery on acetylcholine 
(ACh, 1 nmol/l - 10 μmol/l) in Wistar-Kyoto (WKY, A), borderline hypertensive (BHR, B) and spontaneously hypertensive (SHR, C) rats. 
Rings were exposed to increasing concentrations of ACh in –log mol/l units (see charts). The time axis intervals represent 10 minutes. 
Charts of BHR and SHR femoral artery depicting impaired relaxation responses at higher ACh concentrations as compared to maximal 
relaxation at lower-concentrations of ACh, indicating release of counterbalancing vasocontractile factors in hypertensive animals. 
D shows the typical contraction response to noradrenaline (NA, 10 μmol/l) in WKY rats. 
 
 
relaxation calculated as the difference between total 
relaxation (Figs 3A and 4A) and L-NAME-resistant 
relaxation (Figs 3B and 4B) are shown in Fig. 5A and 
Fig. 5B. The NO-independent component of ACh-
induced relaxation was decreased in BHR (12.61±1.47 
a.u. as compared to 17.49±1.83 a.u. in WKY, p<0.05) 
and SHR (7.32±1.68 a.u. as compared to WKY and 
BHR, p<0.05). There was also a significant negative 
correlation between BP and absolute NO-independent 
vasorelaxation (r=−0.656, p=0.0004, n=25). Moreover, 
significant negative correlations were found between 
systolic BP and relative NO-independent vasorelaxation 
(Fig. 6A). 
  Cumulative addition of NO donor sodium 
nitroprusside (SNP) produced similar relaxation 
responses in the femoral artery from BHR, SHR and 
WKY rats (Figs 3C, 4C). 
 
Discussion 
 
  The presented study was designed to reveal the 
severity of vascular alterations in adult borderline 
hypertensive rats as compared to normotensive and 
hypertensive rats. Special attention was paid to the NO-
dependent and independent components of vasorelaxation. 
The study revealed attenuated acetylcholine-induced 
relaxation in the serotonin pre-contracted FA of both adult 
BHR and SHR, which was associated with reduction of the 
NO-independent component of relaxation. Additionally, 
there were significant between-strain related alterations in 
mechanism of relaxation resulting in negative correlation 
between BP and NO-independent component and positive 
correlation between BP and NO-dependent component of 
vasorelaxation. Moreover, biochemical analysis showed 
elevated NO production as well as oxidative stress in rats 
with increased BP. 622   Púzserová et al.   Vol. 62 
 
 
       
 
Fig. 3. Vascular responses (absolute changes) to acetylcholine (ACh) in isolated femoral arteries of Wistar-Kyoto (WKY), borderline 
hypertensive (BHR) and spontaneously hypertensive (SHR) rats. In serotonin-contracted rings with endothelium of WKY, BHR and SHR, 
ACh causes relaxations which at higher concentrations are blunted in the arteries of the hypertensive strain. Endothelium-dependent 
relaxations before (A) and after (B) incubation with the nitric oxide (NO) synthase inhibitor N
G-nitro-L-arginine methyl ester (L-NAME, 
i.e. NO-independent component of ACh-induced relaxation); Sodium nitroprusside (SNP)-induced endothelium-independent relaxation 
(C). Values represent mean±SEM of 7-10 rats. **
 p<0.01, *
 p<0.05, compared to respective value in WKY rats; 
++ p<0.01, 
+ p<0.05, 
compared to respective value in BHR rats; 
xx p<0.01, 
x p<0.05, compared to respective value without L-NAME; 
§§ p<0.01, 
§ p<0.05, 
compared to maximal relaxation at ACh concentrations 0.3 µmol/l (A) and 1 µmol/l (B) 
 
 
       
 
Fig. 4. Vascular responses (relative changes) to acetylcholine (ACh) in the isolated femoral arteries of Wistar-Kyoto (WKY), borderline 
hypertensive (BHR) and spontaneously hypertensive (SHR) rats. Relaxation responses were expressed as the percentage of relaxation 
respect to the pre-contraction induced by serotonin (1 µmol/l). The pre-contraction plateau value reached after serotonin administration 
corresponds to 100 %. In serotonin-contracted rings with endothelium of WKY, BHR and SHR, ACh causes relaxations which at higher 
concentrations are blunted in the arteries of the hypertensive strain. Endothelium-dependent relaxations before (A) and after (B) 
incubation with the nitric oxide (NO) synthase inhibitor N
G-nitro-L-arginine methyl ester (L-NAME, i.e. NO-independent component of 
ACh-induced relaxation); Sodium nitroprusside (SNP)-induced endothelium-independent relaxation (C). Values represent mean±SEM of 
7-10 rats. **
 p<0.01, *
 p<0.05, compared to respective value in WKY rats; 
++ p<0.01, 
+ p<0.05, compared to respective value in BHR 
rats; 
xx p<0.01, 
x p<0.05, compared to respective value without L-NAME; 
§§ p<0.01, 
§ p<0.05, compared to maximal relaxation at ACh 
concentrations 0.3 µmol/l (A) and 1 µmol/l (B) 2013   Endothelial Function of Hypertensive Rats    623 
 
 
   
 
Fig. 5. Nitric oxide (NO)-dependent relaxations (relative and absolute changes) in the isolated femoral arteries of Wistar-Kyoto (WKY), 
borderline hypertensive (BHR) and spontaneously hypertensive (SHR) rats. Nitric oxide (NO)-dependent relaxation (in mN/mm) 
calculated as the difference between total acetylcholine (ACh)-induced relaxing curves (Fig. 3A) and L-NAME-resistant relaxation 
(Fig. 3B) (A). Nitric oxide (NO)-dependent relaxation (in percentage) calculated as the difference between total acetylcholine (ACh)-
induced relaxing curves (Fig. 4A) and L-NAME-resistant relaxation (Fig. 4B) (B). Relaxation responses are expressed as the percentage 
of relaxation to the pre-contraction induced by serotonin (1 µmol/l). Values represent mean±SEM of 7-10 rats. L-NAME – N
G-nitro-L-
arginine methyl ester; **
 p<0.01, *
 p<0.05, compared to respective value in WKY rats 
 
 
  Elevated systolic blood pressure in both BHR 
and SHR was accompanied by an increase of relative left 
ventricle mass, indicating left ventricular hypertrophy. It 
is well known that left ventricular hypertrophy results 
from the interaction of systemic hemodynamic overload 
and local non-hemodynamic factors, and thus NO may 
play a significant role in its development. Indeed, in the 
model of NO-deficient hypertension, local reduction of 
NO production rather than hemodynamic overload were 
associated with the degree of LV hypertrophy (Bernátová 
et al. 1999). According to our current data, however, LV 
hypertrophy occurred without alterations in NO 
production in the LV of BHR and even in the presence of 
increased NOS activity in SHR. It is yet to be noted that 
the oxidative stress markers were increased in the LV of 
both BHR and SHR. Thus oxidative stress may contribute 
to the development of hypertrophy induced by multiple 
mechanisms including G-protein-coupled receptor 
agonists and mechanical stretch (Grieve et al. 2006) as 
well as reduction of NO bioavailability in the LV 
(Pechánová et al. 2007, 2009). Similarly, vascular wall 
remodeling is common feature in hypertension (Paulis et 
al. 2007, 2008). We observed reduced internal diameter 
in the FA in SHR and increased diameter in BHR without 
alterations in resting wall tension, which suggest no 
changes in the passive elements of the vascular wall 
(Koprdova et al. 2009). In fact we observed that internal 
diameter in the FA correlated positively with BM. 
  As mentioned above, despite enormous effort, 
the mechanisms underlying ED in hypertension are not 
satisfactorily understood and methodological aspects 
represent a significant limitation of our current 
knowledge. In contrast to our previous findings of 
unchanged ACh-induced relaxation in the phenylephrine 
(Phe) pre-contracted FA of BHR and even improved 
relaxation in SHR vs. WKY rats (Púzserová et al. 2007) 
and vs. Wistar rats (Bernatova et al. 2007), our current 
study revealed ED in both BHR and SHR as compared to 
WKY. Since between-strain differences were detected in 
the magnitude of pre-contraction induced by serotonin, 
the role of differences in pre-relaxation tone cannot be 
rule out (Li and Bukoski 1993). As Hansen and 
Nedergaard (1999) have previously demonstrated that the 
ACh-induced relaxation was inversely related to 
precontractile tension when expressed as a percentage, 
but independent when expressed in absolute values, 624   Púzserová et al.   Vol. 62 
 
 
   
 
Fig. 6. Vascular responses (relative changes) to acetylcholine (ACh) in the isolated femoral arteries of Wistar-Kyoto (WKY), borderline 
hypertensive (BHR) and spontaneously hypertensive (SHR) rats. Correlation between NO-independent component of vasorelaxation 
(calculated from relative relaxations) and blood pressure (A). Correlation between NO-dependent component of vasorelaxation 
(calculated from relative relaxations) and blood pressure (B). Values represent mean±SEM of 7-10 rats. AUC – area under the curve 
 
 
vasorelaxations in this study were determined also in 
absolute values. The results calculated on the basis of 
absolute tension were similar to those obtained in 
percentages (Fig. 3, Fig. 4), however, determination of 
relaxation in absolute values revealed a more pronounced 
ED in SHR vs. BHR, which was not associated with NO 
deficiency. The present results also suggest that the 
responsiveness of vascular smooth muscles to NO was 
not impaired since relaxant responses to SNP were 
unchanged. Differences in our studies were presumably 
related to methodological aspects. Namely, relaxant 
responses to ACh were determined in serotonin 
(Fujimoto and Fujimoto 2001) pre-contracted arteries 
instead of phenylephrine (Bernatova et al. 2007, 
Púzserová  et al. 2007) in order to avoid spontaneous 
relaxation, which can occur in the Phe pre-contracted FA. 
In this context, it has been reported that endothelium-
dependent vasorelaxation of SHR resistance arteries is 
not impaired under any conditions and appears to be a 
function of the agonist used to pre-constrict the vessels 
(Li and Bukoski 1993). 
  Moreover, addition of antioxidants, e.g. ascorbic 
acid (AsA), to solution (to PSS or to solution for dilution 
of some drugs) used in vascular in vitro studies may also 
be of importance (Bernatova et al. 2009). In addition to 
above mentioned modifications, our previous 
observations of the absence of ED in BHR and SHR were 
achieved in the presence of AsA (Bernatova et al. 2007, 
Púzserová et al. 2007). Similarly to our studies, absence 
of ED was shown in the presence of AsA in various 
arteries of adult SHR (Török and Kristek 2001, 
Cacányiová and Kristek 2008, Lísková et al. 2010). 
However, AsA might artificially reverse ED by 
improvement of oxidative status resulting in better NO 
bioavailability (May 2000, Bernatova et al. 2009). On the 
other hand, preserved ACh-induced relaxation was 
reported also in the adult SHR aorta in absence of 
antioxidants (Lorkowska et al. 2006). Furthermore even 
greater relaxation responses were observed in the adult 
SHR FA compared to their normotensive counterparts 
(Konishi and Su 1983). On the contrary, a reduced ACh-
induced vasorelaxation was reported in the iliac artery in 
SHR in the presence of AsA (Cacányiová et al. 2006). 
  The investigation of vasorelaxation by 
cumulative addition of ACh revealed also considerable 
differences in the course of vascular responses of WKY, 
BHR and SHR, mainly at higher ACh concentrations. It 
is well known that higher concentrations of ACh may 2013   Endothelial Function of Hypertensive Rats    625 
 
 
elicit production of endothelium-derived vasoconstrictive 
cyclooxygenase-generated prostaglandins in adult SHR 
arteries, simultaneously with EDRFs (Lüscher and 
Vanhoutte 1986, Jameson et al. 1993, Vanhoutte 2009). 
Previously reported EDCFs include endothelin, 
cyclooxygenase-derived prostanoids or free radicals (Li 
and Bukoski 1993, Paulis et al. 2008, Török 2008, 
Cacányiová and Kristek 2008, Vanhoutte et al. 2005, 
Vanhoutte 2009). The dysbalance between EDRFs and 
EDCFs was shown to be progressively increasing not 
only with advancing age, but also by hypertension 
development (Líšková et al. 2011). Similarly, in this 
study the EDCFs release was present only in hypertensive 
animals as determined by stronger depression of 
relaxation curves at higher concentration (more than 
1 μmol/l in this study) of acetylcholine compared to 
normotensive animals. Moreover, the release of EDCFs 
was not observed in age-matched WKY rats, similarly as 
it was found previously (Líšková et al. 2011). In contrast, 
the EDCFs-mediated contractions were not seen in the 
FA of BHR and SHR pre-contracted with phenylephrine 
in the presence of AsA (Púzserová et al. 2007), which is 
in agreement with the idea that reactive oxygen species, 
namely superoxide anion, accelerate endothelium-
dependent contractions to ACh in SHR (Jameson et al. 
1993, Vanhoutte et al. 2005, Vanhoutte 2009). 
Furthermore, the EDCFs-mediated contractile responses 
in the FA of BHR and SHR were augmented after pre-
incubation with L-NAME, suggesting that NO 
counterbalances the effect of EDCFs. 
  An interesting result of this study was the 
observation of reduced NO-independent (i.e. L-NAME- 
resistant) component of ACh-induced relaxation. It is an 
important finding as many studies investigating vascular 
function by ACh test assume that NO deficiency is the 
major factor of endothelial dysfunction. As the N
G-nitro-
L-arginine (an inhibitor of NOS) in the combination with 
tetraethylammonium or charybdotoxin (inhibitors of 
EDHFs-mediated responses) and indomethacin 
(cyclooxygenase inhibitor) completely abolished the 
relaxant response to ACh in the adult SHR femoral artery 
(Fujimoto and Fujimoto 2001) we assume that the NO-
independent component is related to endothelium-derived 
hyperpolarizing factors and PGI2 dependent 
vasorelaxation in this artery. This study showed that ED 
(at least in the femoral artery) observed in experimental 
model of genetic prehypertension and hypertension was 
related rather to the decreased EDHFs-mediated and/or 
PGI2-mediated vasorelaxation (Li et al. 1994, Kähönen et 
al. 1995, Fujimoto and Fujimoto 2001, Mori et al. 2006) 
than to lack of NO. Indeed, there was positive correlation 
between NO-dependent component of relaxation and BP, 
similarly as we observed previously (Púzserová et al. 
2007). 
  Also of interest is our observation that maximal 
ACh-induced relaxation of SHR vessels was inhibited by 
L-NAME, whereas this blocker was without effect on 
maximal relaxations of WKY and BHR vessels. Similar 
observations were reported by Li and Bukoski (1993). 
This observation suggests that compensatory EDHFs 
production may occur in normotensive rats after acute 
NOS inhibition (Bauersachs et al. 1996) while this 
mechanism is impaired in SHR rats (Púzserová et al. 
2010). 
  Regarding vasoconstriction, this study 
demonstrated that phasic and tonic contractile responses 
to noradrenaline were larger in SHR than in WKY. 
Similar findings were observed by Asano et al. (1982) in 
the FA of adult female SHR, which was associated with 
the decrease in β-adrenoceptor relaxing responses and 
accompanied by an enhanced vasoconstriction induced by 
NA. Reduced β-adrenoceptor-mediated relaxation was 
found in the femoral artery in adult SHR males (Konishi 
and Su 1983) as well as in young SHR males in the 
prehypertensive period (Fujimoto et al. 1987). Thus it is 
likely that a decrease in β-adrenoceptor activity would 
result in potentiation of vasoconstriction by unopposed α-
adrenoceptor stimulation (Asano et al. 1982). Our results 
also suggest differences in sensitivity and/or distribution 
of alpha and beta adrenoceptors between adult BHR and 
SHR since NA-induced tonic vasoconstriction of BHR 
was similar to that in WKY and significantly lower 
compared to SHR. Additionally, Líšková et al. (2011) 
suggested the enhanced contribution of EDCFs in NA-
induced contraction of the femoral arteries in adult SHR.  
  Biochemical findings support the idea that the L-
arginine/NO system may serve as a compensatory 
mechanism activated in response to increased blood 
pressure in SHR, because NO is known to counterbalance 
the effect of sympathetic stimulation on the peripheral as 
well as central level (Török 2008). Indeed, several 
studies, including ours, observed elevated NO production 
in SHR (Chen and Hu 1997, Radaelli et al. 1998, Vaziri 
et al. 2000, Zalba et al. 2001, Hojná et al. 2007, 
Pechánová  et al. 2007, 2009, Púzserová et al. 2007, 
Török 2008). Considering the presence of oxidative 
stress, elevated NO production may be a consequence of 
free radical-induced activation of NF-κB, transcriptional 626   Púzserová et al.   Vol. 62 
 
 
factor for NOS (Kopincová et al. 2011). On the other 
hand, oxidative load may also reduce NO bioavailability 
(Pechánová et al. 2007), so that NO may be unable to 
induce greater NO-dependent vasodilatation, despite 
increased vascular NO synthesis. Moreover, even though 
NO-dependent vasorelaxation was not reduced in 
hypertensive rats, we cannot exclude relative NO 
deficiency as compared to the existing sympathetic 
overactivity (Kunes et al. 2004, Paulis et al. 2007, Török 
2008, Behuliak et al. 2011) as suggested by increased 
drinking volume (Kraly et al. 1985) and elevated HR in 
SHR as compared to both WKY and BHR. 
  The observations of elevated CD and TBARS 
support the idea that oxidative stress may be a factor 
contributing to LV hypertrophy as well as ED in genetic 
hypertension. However, persistent elevation of NO and 
superoxide levels can result in generation of 
peroxynitrite, a potent oxidant and tissue-damaging 
agent, resulting in impairment of cellular signaling 
(Durackova 2010, Kopincová et al. 2011). It is thus not 
clear whether NO would remain a protective 
compensatory molecule over a prolonged time-course of 
hypertension. Taking into account all aforementioned 
results, the reduced endothelium-dependent relaxations to 
ACh in the femoral arteries of BHR and SHR were not 
due to a decreased release of NO but rather to other 
EDRFs and/or to the simultaneous release of EDCFs. 
  In conclusion, this study showed that LV 
hypertrophy and ED were present in both adult BHR and 
SHR. Moreover, the results revealed that the degree of 
ED was associated with the level of BP. LV hypertrophy 
and ED observed in this study did not result from reduced 
NO synthesis. The most important finding of this study 
was that the NO-independent component of endothelium-
dependent ACh-induced relaxation in serotonin pre-
contracted FA correlated negatively with BP. Thus, the 
results suggest that both in BHR and SHR rats, ED was 
not associated with reduced NO production. Additionally, 
the results indicate that borderline hypertension in 
adulthood represents qualitatively a similar risk of other 
cardiovascular diseases as does fully developed 
hypertension. Therefore it is important to study vascular 
mechanisms in conditions of moderately increased blood 
pressure in order to prevent pressure-induced organ 
damage, which can further accelerate the development of 
serious hypertension. 
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